Bipolar disorder staging and the impact it has on its management: an update.

Bipolar disorder management progression staging bipolar disorder staging models

Journal

Expert review of neurotherapeutics
ISSN: 1744-8360
Titre abrégé: Expert Rev Neurother
Pays: England
ID NLM: 101129944

Informations de publication

Date de publication:
16 May 2024
Historique:
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 16 5 2024
Statut: aheadofprint

Résumé

The longitudinal course of bipolar disorder (BD) is associated with an active process of neuroprogression, characterized by structural brain alterations and progressive functional impairment. In the last decades, a growing need of a standardized staging model for BD arose, with the aim of a more appropriate definition of stage-specific clinical manifestations and the identification of more customized therapeutic tools. The authors review the literature on clinical aspects, neurobiological correlates and treatment issues related to BD progression. Thereafter, they address the definition, constructs, and evolution of the staging concept, focusing on the clinical applications of BD staging models available in literature. Although several staging models for BD have been proposed to date, their application in clinical practice is still relatively scant. This may have a detrimental impact on the clinical and therapeutic management of BD, in terms of early and proper diagnosis as well as tailored treatment interventions according to the different stages of illness. Future research efforts should tend to the integration of recent insights on neuroimaging and epigenetic markers, toward a standardized and multidimensional staging model.

Identifiants

pubmed: 38753491
doi: 10.1080/14737175.2024.2355264
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Bernardo Dell'Osso (B)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.
CRC "Aldo Ravelli" for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Department of Psychiatry and Behavioural Sciences, Stanford University, Stanford, CA, USA.

Laura Cremaschi (L)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Monica Macellaro (M)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.
CRC "Aldo Ravelli" for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.

Rita Cafaro (R)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Nicolaja Girone (N)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Classifications MeSH